Alex Gibson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Alex Gibson has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Chris Schaffer
Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA
1 shared publication - David Owen Bates
University of Nottingham
1 shared publication - Lucy Frances Donaldson
School of Life Sciences, The Medical School QMC, University of Nottingham, UK
1 shared publication - Lydia D. Hardowar
School of Science and Technology , Nottingham Trent University , Nottingham , UK , ntu.ac.uk
1 shared publication - Marlene E. Da Vitoria Lobo
Institute of Ophthalmology, University College London, London, UK
1 shared publication - Masanori Hirashima
Division of Pharmacology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
1 shared publication
Latest Publications
- Open Access
- 29 March 2022
- Published by Wolters Kluwer Health in Pain
- Vol. 163 (11) , 2264-2279
Hypoxia-induced carbonic anhydrase mediated dorsal horn neuron activation and induction of neuropathic pain
Neuropathic pain, such as that seen in diabetes mellitus, results in part from central sensitisation in the dorsal horn. However, the mechanisms responsible for such sensitisation remain unclear. There is evidence that disturbances in the integrity of the spinal vascular network can be causative factors in the development of neuropathic pain. Here we show that reduced blood flow and vascularity of the dorsal horn leads to the onset of neuropathic pain. Using rodent models (type 1 diabetes and an inducible endothelial-specific vascular endothelial growth factor receptor 2 knockout mouse) that result in degeneration of the endothelium in the dorsal horn, we show that spinal cord vasculopathy results in nociceptive behavioural hypersensitivity. This also results in increased hypoxia in dorsal horn neurons, depicted by increased expression of hypoxia markers such as hypoxia inducible factor 1α, glucose transporter 3, and carbonic anhydrase 7. Furthermore, inducing hypoxia through intrathecal delivery of dimethyloxalylglycine leads to the activation of dorsal horn neurons as well as mechanical and thermal hypersensitivity. This shows that hypoxic signalling induced by reduced vascularity results in increased hypersensitivity and pain. Inhibition of carbonic anhydrase activity, through intraperitoneal injection of acetazolamide, inhibited hypoxia-induced pain behaviours. This investigation demonstrates that induction of a hypoxic microenvironment in the dorsal horn, as occurs in diabetes, is an integral process by which neurons are activated to initiate neuropathic pain states. This leads to the conjecture that reversing hypoxia by improving spinal cord microvascular blood flow could reverse or prevent neuropathic pain.
- 29 March 2022
- Published by Wolters Kluwer Health in Pain
- Vol. 163 (11) , 2264-2279
Open AccessHypoxia-induced carbonic anhydrase mediated dorsal horn neuron activation and induction of neuropathic pain
Neuropathic pain, such as that seen in diabetes mellitus, results in part from central sensitisation in the dorsal horn. However, the mechanisms responsible for such sensitisation remain unclear. There is evidence that disturbances in the integrity of the spinal vascular network can be causative factors in the development of neuropathic pain. Here we show that reduced blood flow and vascularity of the dorsal horn leads to the onset of neuropathic pain. Using rodent models (type 1 diabetes and an inducible endothelial-specific vascular endothelial growth factor receptor 2 knockout mouse) that result in degeneration of the endothelium in the dorsal horn, we show that spinal cord vasculopathy results in nociceptive behavioural hypersensitivity. This also results in increased hypoxia in dorsal horn neurons, depicted by increased expression of hypoxia markers such as hypoxia inducible factor 1α, glucose transporter 3, and carbonic anhydrase 7. Furthermore, inducing hypoxia through intrathecal delivery of dimethyloxalylglycine leads to the activation of dorsal horn neurons as well as mechanical and thermal hypersensitivity. This shows that hypoxic signalling induced by reduced vascularity results in increased hypersensitivity and pain. Inhibition of carbonic anhydrase activity, through intraperitoneal injection of acetazolamide, inhibited hypoxia-induced pain behaviours. This investigation demonstrates that induction of a hypoxic microenvironment in the dorsal horn, as occurs in diabetes, is an integral process by which neurons are activated to initiate neuropathic pain states. This leads to the conjecture that reversing hypoxia by improving spinal cord microvascular blood flow could reverse or prevent neuropathic pain.